Literature DB >> 29736866

Metastatic breast cancer patients' expectations and priorities for symptom improvement.

Danielle B Tometich1, Catherine E Mosher2, Adam T Hirsh2, Kevin L Rand2, Shelley A Johns3,4, Marianne S Matthias3,4,5,6, Samantha D Outcalt3,4,5,7, Bryan P Schneider8, Lida Mina9, Anna Maria V Storniolo8, Erin V Newton8, Kathy D Miller8.   

Abstract

PURPOSE: Little research has examined cancer patients' expectations, goals, and priorities for symptom improvement. Thus, we examined these outcomes in metastatic breast cancer patients to provide patients' perspectives on clinically meaningful symptom improvement and priorities for symptom management.
METHODS: Eighty women with metastatic breast cancer participated in a survey with measures of comorbidity, functional status, engagement in roles and activities, distress, quality of life, and the modified Patient-Centered Outcomes Questionnaire that focused on 10 common symptoms in cancer patients.
RESULTS: On average, patients reported low to moderate severity across the 10 symptoms and expected symptom treatment to be successful. Patients indicated that a 49% reduction in fatigue, 48% reduction in thinking problems, and 43% reduction in sleep problems would represent successful symptom treatment. Cluster analysis based on ratings of the importance of symptom improvement yielded three clusters of patients: (1) those who rated thinking problems, sleep problems, and fatigue as highly important, (2) those who rated pain as moderately important, and (3) those who rated all symptoms as highly important. The first patient cluster differed from other subgroups in severity of thinking problems and education.
CONCLUSIONS: Metastatic breast cancer patients report differing symptom treatment priorities and criteria for treatment success across symptoms. Considering cancer patients' perspectives on clinically meaningful symptom improvement and priorities for symptom management will ensure that treatment is consistent with their values and goals.

Entities:  

Keywords:  Expectation; Metastatic breast cancer; Patient-centered; Priorities; Symptom; Treatment outcome

Mesh:

Year:  2018        PMID: 29736866      PMCID: PMC6221997          DOI: 10.1007/s00520-018-4244-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  41 in total

1.  New English and Spanish social health measures will facilitate evaluating health determinants.

Authors:  Elizabeth A Hahn; Darren A DeWalt; Rita K Bode; Sofia F Garcia; Robert F DeVellis; Helena Correia; David Cella
Journal:  Health Psychol       Date:  2014-01-20       Impact factor: 4.267

Review 2.  Symptoms and symptom management in long-term cancer survivors.

Authors:  Rahul Gosain; Kenneth Miller
Journal:  Cancer J       Date:  2013 Sep-Oct       Impact factor: 3.360

3.  Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.

Authors:  Erin E Kent; Rochelle Malinoff; Heather M Rozjabek; Anita Ambs; Steven B Clauser; Marie A Topor; Gigi Yuan; James Burroughs; Anne B Rodgers; Kimberly DeMichele
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

4.  Improved survival in metastatic breast cancer 1985-2016.

Authors:  Marie Sundquist; Lars Brudin; Göran Tejler
Journal:  Breast       Date:  2016-11-02       Impact factor: 4.380

5.  Defining patient-centered, multidimensional success criteria for treatment of chronic spine pain.

Authors:  Jennifer L Brown; Penny S Edwards; James W Atchison; Ann Lafayette-Lucey; Virgil T Wittmer; Michael E Robinson
Journal:  Pain Med       Date:  2008-10       Impact factor: 3.750

6.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

7.  Should patient-rated performance status affect treatment decisions in advanced lung cancer?

Authors:  Esther Dajczman; Goulnar Kasymjanova; Harvey Kreisman; Nelda Swinton; Carmela Pepe; David Small
Journal:  J Thorac Oncol       Date:  2008-10       Impact factor: 15.609

8.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Lymphedema after treatment of breast cancer.

Authors:  Cihangir Ozaslan; Bekir Kuru
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

10.  The role of education and intellectual activity on cognition.

Authors:  Jeanine M Parisi; George W Rebok; Qian-Li Xue; Linda P Fried; Teresa E Seeman; Elizabeth K Tanner; Tara L Gruenewald; Kevin D Frick; Michelle C Carlson
Journal:  J Aging Res       Date:  2012-08-09
View more
  4 in total

1.  CORR Insights®: Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Metastatic Bone Disease from Lung Cancer? A Systematic Review and Network Meta-Analysis.

Authors:  Darin Davidson
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

2.  Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.

Authors:  Danielle B Tometich; Brent J Small; Judith E Carroll; Wanting Zhai; George Luta; Xingtao Zhou; Lindsay C Kobayashi; Tim Ahles; Andrew J Saykin; Jonathan D Clapp; Heather S L Jim; Paul B Jacobsen; Arti Hurria; Deena Graham; Brenna C McDonald; Neelima Denduluri; Martine Extermann; Claudine Isaacs; Asma Dilawari; James Root; Christine Rini; Jeanne S Mandelblatt
Journal:  J Pain Symptom Manage       Date:  2018-11-23       Impact factor: 3.612

3.  Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced lung cancer.

Authors:  Ellen Krueger; Ekin Secinti; Wei Wu; Nasser Hanna; Gregory Durm; Lawrence Einhorn; Shadia Jalal; Catherine E Mosher
Journal:  Support Care Cancer       Date:  2021-03-24       Impact factor: 3.359

4.  Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.

Authors:  Ami Vyas; Tyler Mantaian; Shweta Kamat; Sobha Kurian; Stephen Kogut
Journal:  J Geriatr Oncol       Date:  2021-06-05       Impact factor: 3.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.